Does the media prefer APYX or SGP?

In the previous week, Apyx Medical had 6 more articles in the media than Spyglass Pharma. MarketBeat recorded 12 mentions for Apyx Medical and 6 mentions for Spyglass Pharma. Apyx Medical's average media sentiment score of 1.14 beat Spyglass Pharma's score of -0.12 indicating that Apyx Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spyglass Pharma 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor TCMD or APYX?

In the previous week, Apyx Medical had 10 more articles in the media than Tactile Systems Technology. MarketBeat recorded 12 mentions for Apyx Medical and 2 mentions for Tactile Systems Technology. Apyx Medical's average media sentiment score of 1.14 beat Tactile Systems Technology's score of 0.42 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tactile Systems Technology 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Apyx Medical 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, MDXG or APYX?

MiMedx Group has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiMedx Group $418.63M 1.54 $48.58M $0.20 21.65 Apyx Medical $52.84M 3.23 -$11.21M -$0.22 N/A

Is MDXG or APYX more profitable?

MiMedx Group has a net margin of 7.88% compared to Apyx Medical's net margin of -16.40%. MiMedx Group's return on equity of 21.03% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets MiMedx Group 7.88% 21.03% 15.92% Apyx Medical -16.40% -88.47% -14.94%

Does the media prefer MDXG or APYX?

In the previous week, Apyx Medical had 10 more articles in the media than MiMedx Group. MarketBeat recorded 12 mentions for Apyx Medical and 2 mentions for MiMedx Group. Apyx Medical's average media sentiment score of 1.14 beat MiMedx Group's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Apyx Medical 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is NPCE or APYX more profitable?

Apyx Medical has a net margin of -16.40% compared to NeuroPace's net margin of -21.67%. Apyx Medical's return on equity of -88.47% beat NeuroPace's return on equity. Company Net Margins Return on Equity Return on Assets NeuroPace -21.67% -108.20% -18.50% Apyx Medical -16.40% -88.47% -14.94%

Does the media prefer NPCE or APYX?

In the previous week, Apyx Medical had 11 more articles in the media than NeuroPace. MarketBeat recorded 12 mentions for Apyx Medical and 1 mentions for NeuroPace. Apyx Medical's average media sentiment score of 1.14 beat NeuroPace's score of 0.87 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is BWAY or APYX more profitable?

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -16.40%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Brainsway 15.68% 12.28% 7.75% Apyx Medical -16.40% -88.47% -14.94%

Does the media refer more to BWAY or APYX?

In the previous week, Apyx Medical had 3 more articles in the media than Brainsway. MarketBeat recorded 12 mentions for Apyx Medical and 9 mentions for Brainsway. Apyx Medical's average media sentiment score of 1.14 beat Brainsway's score of 0.83 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainsway 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Apyx Medical (APYX) Competitors

$4.13 -0.15 (-3.50%)

As of 09:47 AM Eastern

Compare

APYX vs. SGP, TCMD, MDXG, NPCE, and BWAY

Should you buy Apyx Medical stock or one of its competitors? MarketBeat compares Apyx Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Apyx Medical include Spyglass Pharma (SGP), Tactile Systems Technology (TCMD), MiMedx Group (MDXG), NeuroPace (NPCE), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry.

How does Apyx Medical compare to Spyglass Pharma?

Apyx Medical (NASDAQ:APYX) and Spyglass Pharma (NASDAQ:SGP) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

Apyx Medical presently has a consensus price target of $6.60, suggesting a potential upside of 62.16%. Spyglass Pharma has a consensus price target of $45.00, suggesting a potential upside of 124.78%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Spyglass Pharma is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Spyglass Pharma	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Apyx Medical had 6 more articles in the media than Spyglass Pharma. MarketBeat recorded 12 mentions for Apyx Medical and 6 mentions for Spyglass Pharma. Apyx Medical's average media sentiment score of 1.14 beat Spyglass Pharma's score of -0.12 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spyglass Pharma	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Spyglass Pharma has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Spyglass Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.23	-$11.21M	-$0.22	N/A
Spyglass Pharma	N/A	N/A	N/A	-$6.41	N/A

Spyglass Pharma has a net margin of 0.00% compared to Apyx Medical's net margin of -16.40%. Spyglass Pharma's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Spyglass Pharma	N/A	N/A	N/A

55.3% of Apyx Medical shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Apyx Medical and Spyglass Pharma tied by winning 7 of the 14 factors compared between the two stocks.

How does Apyx Medical compare to Tactile Systems Technology?

Tactile Systems Technology (NASDAQ:TCMD) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Tactile Systems Technology has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.94	$19.09M	$0.88	32.26
Apyx Medical	$52.84M	3.23	-$11.21M	-$0.22	N/A

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tactile Systems Technology presently has a consensus price target of $38.60, suggesting a potential upside of 35.96%. Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 62.16%. Given Apyx Medical's higher possible upside, analysts clearly believe Apyx Medical is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

In the previous week, Apyx Medical had 10 more articles in the media than Tactile Systems Technology. MarketBeat recorded 12 mentions for Apyx Medical and 2 mentions for Tactile Systems Technology. Apyx Medical's average media sentiment score of 1.14 beat Tactile Systems Technology's score of 0.42 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Apyx Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tactile Systems Technology has a net margin of 5.91% compared to Apyx Medical's net margin of -16.40%. Tactile Systems Technology's return on equity of 9.70% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
Apyx Medical	-16.40%	-88.47%	-14.94%

Tactile Systems Technology has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Summary

Tactile Systems Technology beats Apyx Medical on 9 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

MiMedx Group currently has a consensus target price of $8.50, indicating a potential upside of 96.30%. Apyx Medical has a consensus target price of $6.60, indicating a potential upside of 62.16%. Given MiMedx Group's higher probable upside, equities analysts plainly believe MiMedx Group is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

MiMedx Group has a net margin of 7.88% compared to Apyx Medical's net margin of -16.40%. MiMedx Group's return on equity of 21.03% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
Apyx Medical	-16.40%	-88.47%	-14.94%

In the previous week, Apyx Medical had 10 more articles in the media than MiMedx Group. MarketBeat recorded 12 mentions for Apyx Medical and 2 mentions for MiMedx Group. Apyx Medical's average media sentiment score of 1.14 beat MiMedx Group's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Apyx Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiMedx Group has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market.

MiMedx Group has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$418.63M	1.54	$48.58M	$0.20	21.65
Apyx Medical	$52.84M	3.23	-$11.21M	-$0.22	N/A

79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 2.5% of MiMedx Group shares are owned by company insiders. Comparatively, 15.9% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

MiMedx Group beats Apyx Medical on 11 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

In the previous week, Apyx Medical had 11 more articles in the media than NeuroPace. MarketBeat recorded 12 mentions for Apyx Medical and 1 mentions for NeuroPace. Apyx Medical's average media sentiment score of 1.14 beat NeuroPace's score of 0.87 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	5.37	-$21.47M	-$0.65	N/A
Apyx Medical	$52.84M	3.23	-$11.21M	-$0.22	N/A

78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 19.2% of NeuroPace shares are owned by insiders. Comparatively, 15.9% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NeuroPace has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market.

NeuroPace currently has a consensus price target of $18.83, suggesting a potential upside of 19.58%. Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 62.16%. Given Apyx Medical's higher probable upside, analysts plainly believe Apyx Medical is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

Apyx Medical has a net margin of -16.40% compared to NeuroPace's net margin of -21.67%. Apyx Medical's return on equity of -88.47% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.67%	-108.20%	-18.50%
Apyx Medical	-16.40%	-88.47%	-14.94%

Summary

Apyx Medical beats NeuroPace on 9 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to Brainsway?

Brainsway (NASDAQ:BWAY) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

In the previous week, Apyx Medical had 3 more articles in the media than Brainsway. MarketBeat recorded 12 mentions for Apyx Medical and 9 mentions for Brainsway. Apyx Medical's average media sentiment score of 1.14 beat Brainsway's score of 0.83 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Brainsway	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -16.40%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Brainsway	15.68%	12.28%	7.75%
Apyx Medical	-16.40%	-88.47%	-14.94%

Brainsway has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market.

30.1% of Brainsway shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Comparatively, 15.9% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Brainsway has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Brainsway	$52.22M	12.68	$7.57M	$0.35	47.14
Apyx Medical	$52.84M	3.23	-$11.21M	-$0.22	N/A

Brainsway presently has a consensus price target of $15.67, suggesting a potential downside of 5.05%. Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 62.16%. Given Apyx Medical's higher possible upside, analysts plainly believe Apyx Medical is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Brainsway	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

Brainsway beats Apyx Medical on 9 of the 15 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$179.38M	$8.90B	$6.89B	$12.28B
Dividend Yield	N/A	2.48%	2.67%	9.39%
P/E Ratio	-18.50	16.04	27.07	23.95
Price / Sales	3.23	6.77	519.31	90.33
Price / Cash	N/A	18.55	26.68	47.25
Price / Book	10.44	3.26	10.62	6.14
Net Income	-$11.21M	$230.22M	$3.60B	$331.74M
7 Day Performance	-3.55%	-1.77%	-1.26%	-1.82%
1 Month Performance	-0.97%	-1.97%	1.07%	-1.45%
1 Year Performance	81.70%	-0.92%	23.63%	16.32%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	3.3841 of 5 stars	$4.13 -3.5%	$6.60 +59.8%	+80.1%	$173.09M	$52.84M	N/A	270
SGP Spyglass Pharma	1.7095 of 5 stars	$19.99 +0.5%	$45.00 +125.1%	N/A	$668.33M	N/A	N/A	65
TCMD Tactile Systems Technology	3.8935 of 5 stars	$27.62 -4.9%	$38.60 +39.8%	+198.2%	$655.03M	$329.52M	31.39	1,086
MDXG MiMedx Group	2.7377 of 5 stars	$4.20 +2.9%	$8.50 +102.4%	-32.6%	$607.70M	$418.63M	21.00	870	News Coverage
NPCE NeuroPace	2.6781 of 5 stars	$15.84 -7.5%	$18.83 +18.9%	+73.8%	$583.68M	$99.99M	N/A	170

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. SGP, TCMD, MDXG, NPCE, and BWAY

How does Apyx Medical compare to Spyglass Pharma?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Summary

How does Apyx Medical compare to MiMedx Group?

Summary

How does Apyx Medical compare to NeuroPace?

Summary

How does Apyx Medical compare to Brainsway?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. SGP, TCMD, MDXG, NPCE, and BWAY

How does Apyx Medical compare to Spyglass Pharma?

Do analysts prefer APYX or SGP?

Does the media prefer APYX or SGP?

Which has preferable earnings and valuation, APYX or SGP?

Is APYX or SGP more profitable?

Do insiders and institutionals hold more shares of APYX or SGP?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Which has preferable earnings and valuation, TCMD or APYX?

Do institutionals & insiders hold more shares of TCMD or APYX?

Do analysts prefer TCMD or APYX?

Does the media favor TCMD or APYX?

Is TCMD or APYX more profitable?

Which has more volatility and risk, TCMD or APYX?

Summary

How does Apyx Medical compare to MiMedx Group?

Do analysts prefer MDXG or APYX?

Is MDXG or APYX more profitable?

Does the media prefer MDXG or APYX?

Which has more risk and volatility, MDXG or APYX?

Which has preferable earnings and valuation, MDXG or APYX?

Do institutionals and insiders have more ownership in MDXG or APYX?

Summary

How does Apyx Medical compare to NeuroPace?

Does the media prefer NPCE or APYX?

Which has better earnings and valuation, NPCE or APYX?

Do institutionals & insiders hold more shares of NPCE or APYX?

Which has more risk & volatility, NPCE or APYX?

Do analysts prefer NPCE or APYX?

Is NPCE or APYX more profitable?

Summary

How does Apyx Medical compare to Brainsway?

Does the media refer more to BWAY or APYX?

Is BWAY or APYX more profitable?

Which has more volatility & risk, BWAY or APYX?

Do insiders & institutionals have more ownership in BWAY or APYX?

Which has stronger earnings & valuation, BWAY or APYX?

Do analysts prefer BWAY or APYX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools